Why the study?
Does rosuvastatin reduce myocardial infarction injury in an isoproterenol-induced rat model?
Population
Rat model of myocardial infarction injury induced by isoproterenol (ISO) for 2 consecutive days
Comparison
Rosuvastatin administered for 8 weeks vs Isoproterenol-induced rats without rosuvastatin
Design
Preclinical
Follow-up
8 weeks
Authors
Loading...
No immediate clinical implications for MI; leaves open translation of rodent cardioprotection data.
Does rosuvastatin reduce myocardial infarction injury in an isoproterenol-induced rat model?
In a rat model, rosuvastatin alleviates isoproterenol-induced myocardial infarction injury by attenuating oxidative stress and inflammation via NLRP3 inflammasome inhibition.
Yu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: